The JRSR Aims and Scope
The Journal of Rehabilitation Sciences and Research (JRSR) is a quarterly and an editorially independent publication owned by Shiraz School of Rehabilitation Sciences and aims to be a publication of international repute for reporting current regional and international adventures in all aspects of rehabilitation sciences (Physiotherapy, Occupational therapy, Speech therapy, Audiology, Prosthetics & Orthotics, Ergonomy in rehabilitation. JRSR welcomes contributions in this field in the form of original research articles, case reports, letter to the editor, and review articles. The Journal seeks to provide its readers with the highest quality scientific information published through a process of careful double-blind peer reviews and editorial comments. All publications are in English.
The following guidelines refer to the JRSR requirements for receiving your manuscripts for possible publication. Relying on this guideline speeds up the process of evaluation and publication of the submitted paper. We, regretfully, declare the rejection of those contributions that deviate from the Journal Guidelines.
publication fee charge
JRSR charges the following author fees from January 10, 2022.
In an open access model, the publication fee of an article will be paid by an author's research budget, or by their supporting institution, in the form of Article Processing Charges (APC). These allow publishers to make the full-text of every published article freely available to all interested reader. JRSR is an Open Access journal. To follow the instructions for payment please follow this part.
JRSR Journal informs the authors that the journal will receive 1,700,000 Tomansfor publishing the article, of which 200,000 Tomans is related to processing fee and 1,500,000 Tomans is related to acceptance and publication fee. The processing fee will be taken after the editorial checking and before entering the reviewing process and the acceptance and publication fee will be taken from the authors before the official announcement of the acceptance of the article and before the process of preparing and editing the article. The foriegners dont need pay any fee for submision , reviewing and publication.
JRSR will review only English articles that are well written based on English writing principles.
Reviewers who collaborate with the JRSR will receive discounts for publishing their articles in the JRSR.
1. Issues to Consider before Submitting a Manuscript
1.1. Redundant or Duplicate Publication
Redundant or duplicate publication is publication of a paper that overlaps substantially with one already published.
Readers of primary source periodicals deserve to be able to trust that what they are reading is original unless there is a clear statement that the article is being republished by the choice of the author and editor.
The bases of this position are international copyright laws, ethical conduct, and cost effective use of resources.
This policy does not preclude the journal considering a paper that has been rejected by another journal, or a complete report that follows publication of a preliminary report, such as an abstract or poster displayed for colleagues at a professional meeting. Nor does it prevent journals considering a paper that has been presented at a scientific meeting but not published in full or that is being considered for publication in a proceedings or similar format. Press reports of scheduled meetings will not usually be regarded as breaches of this rule, but such reports should not be amplified by additional data or copies of tables and illustrations.
When submitting a paper, the author should always make a full statement to the editor about all submissions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work. The author should alert the editor if the work includes subjects about which a previous report has been published. Any such work should be referred to and referenced in the new paper. Copies of such material should be included with the submitted paper to help the editor decide how to handle the matter.
If redundant or duplicate publication is attempted or occurs without such notification, authors should expect editorial action to be taken. At the least, prompt rejection of the submitted manuscript should be expected.
Preliminary release, usually to public media, of scientific information described in a paper that has been accepted but not yet published violates the policies of many journals. In a few cases, and only by arrangement with the editor, preliminary release of data may be acceptable-for example, if there is a public health emergency.
* This Guideline is an adaptation of Uniform Requirements for Manuscripts, originally written by International Committee of Medical Journal Editors (ICMJE) according to the last updated Vancouver Format in February 2007.
1.2. Acceptable Secondary Publication
Secondary publication in the same or another language, especially in other countries, is justifiable, and can be beneficial, provided all of the following conditions are met.
1. The authors have received approval from the editors of both journals; the editor concerned with secondary publication must have a photocopy, reprint, or manuscript of the primary version.
2. The priority of the primary publication is respected by a publication interval of at least one week (unless specifically negotiated otherwise by both editors).
3. The paper for secondary publication is intended for a different group of readers; an abbreviated version could be sufficient.
4. The secondary version faithfully reflects the data and interpretations of the primary version.
5. The footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part and states the primary reference. A suitable footnote might read: “This article is based on a study first reported in the [title of journal, with full reference].”
Permission for such secondary publication should be free of charge.
1.3. Protection of Patients’ Rights to Privacy
Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published.
Identifying details should be omitted if they are not essential, but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.
1.4. Editorial Policy
The editorial board of The JRSR makes recommendations on all editorial policy decisions. The editorial board meets and before production of each print issue, to determine the editorial position of the unsigned editorial and to assign the writing of that editorial. Regardless of who writes the editorial, responsibility for content remains with the editorial board and the editor-in-chief. Editorials, whether written by the editor-in-chief or another member of the editorial board, must be based on adequate research to demonstrate an accurate understanding of the issue. When necessary, the editor-in-chief is responsible for formulating editorials based on a consensus of the editorial board. If a consensus cannot be reached a vote will be taken. To be approved a proposed editorial must garner positive votes or by consensus will be unsigned and considered the opinion of the paper. The editor-in- chief has the authority to overrule the editorial board and to refuse to allow an editorial topic be addressed in the JRSR.
Although the JRSR is sponsored financially by Shiraz University of Medical Sciences, it benefits from editorial freedom. The editors evaluate and accept articles based only on significance, originality, validity, and adherence to the aims and scope of the Journal.
Our editorial policy is consistent with the principles of editorial independence presented by the World Association of Medical Editors (WAME)
1.6. Ethical Considerations
The journal is a member of the Committee on Publication Ethics (COPE). COPE’s flowcharts and guidelines are approached in confronting any ethical misbehavior. The Journal also follows the guidelines mentioned in the Uniform Requirements for Manuscript Submitted to Biomedical Journals (https://www.icmje.org/icmje-recommendations.pdf).
Human & Animal Rights Statement:
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an independent local, regional or national review body (e.g., ethics committee, institutional review board).
Manuscripts describing any experimental research on animals should include a statement of approval by the Ethical Committee of the institute where the work was done, mentioning that the study was carried out according to the legal requirements of the relevant local or national authority. Before papers describing animal studies are accepted for publication in the Iranian Journal of Medical Sciences, the authors must convince the editors that the work conformed to appropriate ethical standards. The care and use of experimental animals should comply with acceptable international animal welfare guidelines and policies. Further guidance on animal research ethics is available from the Guideline for the Care and Use of Laboratory Animals in Iran. For reports of such studies, authors should refer to the ARRIVE guidelines checklist.
1.7. Informed Consent
All patients and participants in a research project should be thoroughly informed about the aims of the study and any possible side effects of the drugs and interventions. Written informed consent from the participants or their legal guardians is necessary for any such studies. The Journal reserves the right to request the related documents. Articles that require informed consent should contain related statements in the “Methods” section.
Conflict of Interest
We request all the authors to inform us about any kinds of “Conflict of Interest” (such as financial, personal, political, or academic) that would potentially affect their judgment.
Authors are not allowed to utilize verbatim text of previously published papers or manuscripts submitted elsewhere. All submitted manuscripts will be checked for possible similarity in any part of the work by iThenticate plagiarism checker. Based on the amount of plagiarism detected in a manuscript, will be passed to the authors and ask them to rephrase copied phrases or include as direct quotations with references. COPE’s flowcharts and guidelines are approached in cases in which plagiarism is detected.
If a manuscript contains any previous published image or text, it is the responsibility of the author to obtain authorization from copyright holders. The author is required to obtain and submit the written original permission letters for all copyrighted material used in his/her manuscripts.
1.10. Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
This work is licensed under a Creative Commons Attribution 4.0 International License.
1.11. Retraction Policy
The JRSR uses the COPE flowchart for retraction of a published article (http://publicationethics.org/guidelines) to determine whether a published article should be retracted.
2. Requirements for Submission of Manuscripts
2.1. Summary of Technical Requirements
1. Double space all parts of manuscripts
2. Begin each section or component on a new page
3. Insert line number
4. Review the sequence: title page, abstract and keywords, text, acknowledgments, references
5. Illustrations, unmounted prints, should be no larger than 203 x 254 mm. (8 x 10 inches)
6. Include permission to reproduce previously published material or to use illustrations that may identify human subjects
7. State clearly conflict of interest and ethical issue in a cover letter
8. Prepare a full copy of article
9. Keep copies of everything submitted
10. Having filled out and signed JRSR Article Record Form in advance of final submission; 11. Checking the quality of submitted images, illustrations, graphs, charts, diagrams, tables and any other object related to the submission. These formats for images, graphs, illustrations includes high resolution (300 dpi or more) PCX/jpeg/TIFF/pngiBmp. Tables which are designed in Microsoft Word Software must be submitted in original format (i.e. doc). Charts and tables that are released by statistical software such as SPSS must also be submitted in Word or images' formats, but Word format (i.e. doe) is preferred - for this case you may export your tables and charts directly from Statistical Machines like SPSS to Word (XP or 2007). Colored images and illustrations must be submitted in original high quality colors. Any alteration or change to the images' colors must be supported with a notification at the image description clarifying the mainspring. Grayscale (black and white) images and other illustrations should also have high quality resolution and suitable lucidity for conveying the most important details; 12. Be certain to include a camera-ready version of the article; 13. Name the files clearly; 14. Send only the latest version of the manuscript via JRSR site or email.
2.2 Preparing the Manuscripts
The manuscript should be prepared exclusively in Microsoft Word format (2007) with no more than 3000 words, excluding Title, Authors (names and affiliations), and References using Times New Romans font. For details on other than the textual materials see the 2.1section of the guideline.
2.3 Title Page
The title page for both original research and case reports should carry.
The title of the paper, which should be concise but informative. This title should be written with normal writing style (not all capital) and only the initial of the specific names should be capitalized;
2) The name by which each author is known, with his or her highest academic level(s) and institutional affiliation. This also should be written with normal style including the first name followed by surname(s). Individuals should be separated by a coma; The name of the department(s) and institution(s) to which the work should be attributed; Disclaimers, if any; The name, address and affiliation of all authors. The address includes the postal address, telephone and fax numbers followed by a current email address; Source(s) of support in the form of grants, equipment, drugs, or all of these; and, A short running headline of no more than 30 characters (count letters and spaces) at the foot of the title page.
2.4.1: author contributors
All persons designated as authors should qualify for authorship. Each author should have participated sufficiently in the work to take public responsibility for the content.
Authorship credit should be based only on substantial contributions to 1) conception and design, or analysis and interpretation of data; and to 2) drafting the article or reviewing it critically for important intellectual content; and on 3) final approval of the version to be published. Conditions 1, 2, and 3 must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship.
General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author.
Increasingly, multicenter trials are attributed to a corporate author. All members of the group, who are named as authors, either in the authorship position below the title or in a footnote, should fully meet the above criteria for authorship. Group members who do not meet these criteria should be listed, with their permission, in the Acknowledgments.
The order of authorship should be a joint decision of the coauthors. Because the order is assigned in different ways, its meaning cannot be inferred accurately unless it is stated by the authors. Authors may wish to explain the order of authorship in a footnote
2.4.2: non-author contributors
Non-Author Contributors Contributors who meet fewer than all 4 of the above criteria for authorship should not be listed as authors, but they should be acknowledged. Examples of activities that alone (without other contributions) do not qualify a contributor for authorship are acquisition of funding;general supervision of a research group or general
administrative support; and writing assistance, technical editing, language editing, and proofreading. Those whose contributions do not justify authorship may be acknowledged individually or together as a group under a single heading (e.g., “Clinical Investigators” or “Participating Investigators”), and their contributions should be specified (e.g., “served as scientific advisors,”“critically reviewed the study proposal,” “collected data,”“provided and cared for study patients,” “participated in writing or technical editing of the manuscript”).
Because acknowledgment may imply endorsement by acknowledged individuals of a study's data and conclusions, editors are advised to require that the corresponding author obtain written permission to be acknowledged from all acknowledged individuals.
Artificial Intelligence (AI)–Assisted Technology: At submission, the journal should require authors to disclose whether they used artificial intelligence (AI)–assisted technologies (such as Large Language Models [LLMs], chatbots, or image creators) in the production of submitted work. Authors who use such technology should describe, in both the cover letter and the submitted work, how they used it. Chatbots (such as ChatGPT)should not be listed as authors because they cannot be responsible for the accuracy, integrity, and originality of the work, and these responsibilities are required for authorship (see Section II.A.1). Therefore, humans are responsible for any submitted material that included the use of AI-assisted technologies. Authors should carefully
review and edit the result because AI can generate authoritative-sounding output that can be incorrect, incomplete, or biased. Authors should not list AI and AIassisted technologies as an author or co-author, nor cite AI as an author. Authors should be able to assert that there is no plagiarism in their paper, including in text and images produced by the AI. Humans must ensure there is
appropriate attribution of all quoted material, including full citations.
2.5. Abstract and Keywords
The submission should carry an abstract of no more than 300 words for structured abstract in original research articles. This abstract should state:
1. Background (originality and purpose(s) of the study or investigation)
2. Method(s) (selection of study subjects or laboratory animals; observational and analytical methods)
3. Results (giving specific data and their statistical significance, if possible)
4. Conclusion (emphasizing new and important aspects of the study or observations).
The unstructured abstract for a case report should state a summary of the case report with no specific headline but including the main corpus knowledge of the report not exceeding 150 words.
The above mentioned structured abstract can be also used for systematic reviews with maximum to 300 words.
Letters to the editor carry not any abstract
Below the abstract authors should provide, and identify as such, 3 to 5 keywords or short terms selected from the Medical Subject Headings (MeSH).
Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. Discuss the eligibility of experimental subjects. Give details about randomization. Describe the methods for and success of any blinding of observations. Report complications of treatment. Give numbers of observations. Report losses to observation (such as dropouts from a clinical trial). Put a general description of methods in the Methods section. Define statistical terms, abbreviations, and most symbols.
2.7. The Headlines of Original Research Text body
State the purpose of the article and summarize the rationale for the study or observation. Give only strictly pertinent references and do not include data or conclusions from the work being reported.
Describe your selection of the observational or experimental subjects (patients or laboratory animals, including controls) clearly. Identify the age, sex, and other important characteristics of the subjects.
Identify the methods, apparatus (give the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.
Reports of randomized clinical trials should present information on all major study elements, including the protocol (study population, interventions or exposures, outcomes, and the rationale for statistical analysis), assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding).
Present your results or findings in logical sequence in the text, tables, and illustrations. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations.
The behavior of models or specimens should be discussed. It is useful to begin the discussion by summarizing briefly the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and for clinical practice.
Emphasize the new and important aspects of the study and the conclusions that follow from them. Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not completely supported by the data. In particular, authors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, but clearly label them as such. Recommendations, when appropriate, may be included.
2.8. The Headlines of Case Report Text body
Give a very short identification of the specific disease or abnormality you are going to investigate and its originality. If the disease treatment needs a background to be clear for readers include previous treatment(s) as well.
This section includes all informative details about the case and the way he/she has been selected for treatment or report. The case history and prescribe should be included.
You should include your findings in this section in a detailed form so that successors could follow reported treatment or operation.
2.9. The Headings of "Review Article" and "Letter to the Editor" Text body
Review articles' headings are including: background, methods, results, discussion and conclusion.
Submissions of review articles are only expected from experts in the fields.
"Letter to the editor" contribution to JRSR should be totally 1-2 pages involving announcement of innovations, establishments, achievements, and continuation or discontinuation of a method/procedure in the Journal fields. The Letter begins with a suitable concise title and then furthers with an introductory paragraph on the issue's background or author's intention to such contribution.
Acknowledgments should specify 1) contributions that need acknowledging but do not justify authorship, such as general support by a departmental chair; 2) acknowledgments of technical help; 3) acknowledgments of financial and material support, which should specify the nature of the support; and 4) relationships that may pose a conflict of interest.
Acknowledgements are mentioned in a sole paragraph maximum to 30 words. Conflict of interest and financial issues (if any) must be inserted after acknowledgement paragraph.
Persons who have contributed intellectually to the paper but whose contributions do not justify authorship may be named and their function or contribution described-for example, "scientific adviser," "critical review of study proposal," "data collection," or "participation in clinical trial." Such persons must have given their permission to be named. Authors are responsible for obtaining written permission from persons acknowledged by name, because readers may infer their endorsement of the data and conclusions.
2.11. Citations and References
References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in text, tables, and legends by Arabic numerals in square parentheses.
Referencing AI-generated material as the primary source is not acceptable.
Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Consult the List of Journals Indexed in Index Medicus, published annually as a separate publication by the library and as a list in the January issue of Index Medicus. The list can also be obtained through the library’s web site (http://www.nlm.nih.gov). Otherwise, the full title would be included.
Avoid using abstracts as references. References to papers accepted but not yet published should be designated as “in press”; authors should obtain written permission to cite such papers as well as verification that they have been accepted for publication. Information from manuscripts submitted but not accepted should be cited in the text as “unpublished observations” with written permission from the source.
Avoid citing a “personal communication” unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text.
The references must be verified by the author(s) against the original documents.
The references should not exceed 30 references (40 for Review articles) and must follow the Vancouver style including the following items:
1. In-text Citing
A number in square brackets is allocated to a source in the order in which it is cited in the text. If the source is referred to again, the same number is used.
Example: ...as one author has put it “the darkest days were still ahead” : which is well documented in the literature [2-5]. This proves that “the darkest days were still ahead” .
Note: the “[2-5]” refers to references 2 to 5 ( i.e. 2,3,4, and 5) but if you like to mention references 2 AND 5 you should cite them in text as “[2,5]”. Numbers should be inserted to the left of colons, semicolons, and full stops. The author’s name can also be integrated into the text; e.g. Scholtz  has argued that...
Articles in Journals
1. Standard journal article
List the first six authors followed by et al.
Example: Krebs DE, Wong D, Jevsevar D, Riley PO, Hodges WA. Trunk kinematics during locomotor activities. Phys Ther 1999; 72 (7): 505-14.
More than six authors:
Example: Henriksen M, Alkjaer T, Lund H, Simonsen EB, Graven-nielsen T, Danneskiold-Samsøe B, et al. Experimental quadriceps muscle pain impairs knee joint control during walking. J appl physiol 2007; 103: 132-9.
2. Organization as author
Example: The Cardiac Society of Australia and New Zealand. Clinical exercise stress testing. Safety and performance guidelines. Med J Aust 1996; 164:282-4.
3. No author given
Example: Cancer in South Africa [editorial]. S Afr Med J 1994; 84:15.
4. Article not in English
Example: Ryder TE, Haukeland EA, Solhaug JH. Bilateral infrapatellar seneruptur hos tidligere frisk kvinne. Tidsskr Nor Laegeforen 1996; 116:41-2.
5. Volume with supplement
Example: Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994; 102 Suppl 1:275-82.
6. Issue with supplement
Example: Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996; 23(1 Suppl 2):89-97.
7. Volume with part
Example: Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995; 32(Pt 3):303-6.
8. Issue with part
Example: Poole GH, Mills SM. One hundred consecutive cases of flap lacerations of the leg in ageing patients. N Z Med J 1994; 107(986 Pt 1):377-8.
9. Issue with no volume
Example: Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995; (320):110-4.
10. No issue or volume
Example: Browell DA, Lennard TW. Immunologic status of the cancer patient and the effects of blood transfusion on antitumor responses. Curr Opin Gen Surg 1993:325-33.
11. Pagination in Roman numerals
Example: Fisher GA, Sikic BI. Drug resistance in clinical oncology and hematology. Introduction. Hematol Oncol Clin North Am 1995 Apr; 9(2):xi-xii.
12. Type of article indicated as needed
Example 1: Enzensberger W, Fischer PA. Metronome in Parkinson’s disease [letter]. Lancet 1996; 347:1337.
Example 2: Clement J, De Bock R. Hematological complications of hantavirus nephropathy (HVN) [abstract]. Kidney Int 1992; 42:1285.
13. Article containing retraction
Example: Garey CE, Schwarzman AL, Rise ML, Seyfried TN. Ceruloplasmin gene defect associated with epilepsy in EL mice [retraction of Garey CE, Schwarzman AL, Rise ML, Seyfried TN. In: Nat Genet 1994; 6:426-31]. Nat Genet 1995; 11:104.
14. Article retracted
Liou GI, Wang M, Matragoon S. Precocious IRBP gene expression during mouse development [retracted in Invest Ophthalmol Vis Sci 1994; 35:3127]. Invest Ophthalmol Vis Sci 1994; 35:1083-8.
15. Article with published erratum
Hamlin JA, Kahn AM. Herniography in symptomatic patients following inguinal hernia repair [published erratum appears in West J Med 1995; 162:278]. West J Med 1995; 162:28-31.
Books and Other Monographs
(Note: Previous Vancouver style incorrectly had a comma rather than a semicolon between the publisher and the date.)
16. Personal author(s)
Example: Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996. pp. 45-79.
17. Editor(s), compiler(s) as author
Example: Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996. pp. 4-7.
18. Organization as author and publisher
Example: Institute of Medicine (US). Looking at the future of the Medicaid program. Washington: The Institute; 1992. pp. 65-78.
19. Chapter in a book
Example: Hodges PW. Motor control of the trunk. In Boyling JD, Jull GA, editors: Grieve’s Modern Manual Therapy. The vertebral column.3 rd ed. Philadelphia: CHURCHILL LIVINGSTONE: 2004, 119-140.
20. Conference proceedings
Example: Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam: Elsevier; 1996.
21. Conference paper
Example: Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992. p. 1561-5.
Scientific or technical report
Issued by fundinglsponsorine agency:
Example: Smith P. Golladay K. Payment for durable medical equipment billed during skilled nursing facility stays. Final report. Dallas (TX): Dept. of Health and Human Services (US). Office of Evaluation and Inspections: 1994 Oct. Report No.: HHSI-00EI69200860.
Issued by performing agency:
Example: Field NE Tranquada RE. Feasley JC. editors. Health services research: work force and educational issues. Washington: National Academy Press: 1995. Contract No.: AHC'PR282942008. Sponsored by the Agency for Health Care Policy and Research.
Example: Kaplan SJ. Post-hospital home health care: the elderly's access and utilization [dissertation]. St. Louis: Washington Univ.; 1995.
Example: Larsen CE. Trip K Johnson CR. inventors; Novoste Corporation. assignee. Methods for procedures related to the electrophysiology of the heart. US patent 5.529.067. 1995 Jun 25.
Other Published Material
Example: Lee G. Hospitalizations tied to ozone pollution: study estimates 50.000 admissions mutually. The Washington Post 1996 Jun 21: Sect. *3 (col. 5).
Example: HIV+/AIDS: the facts and the future [videocassette]. St. Louis : Mosby-Year Book: 1995.
Example: Preventive Health Amendments of 1993. Pub. L. No. 103-183, 107 Stat. 2226 (Dec. 14, 1993). Unenacted bill:
Example: Medical Records Confidentiality Act of 1995. S. 1360, 104th Cong.. 1st Sess. (1995). Code of Regulations:
Example: Informed Consent. 42 C.F.R. Sect. 441.257 (1995).
Example: Increased Drug Abuse: the Impact on the Nation's Emergency Rooms: Hearings Before the Subcomm. on Human Resources and Intergovernmental Relations of the House Comm. on Government Operations. 103rd Cong.. 1st Sess. (May 26. 1993).
Example: North Carolina. Tuberculosis rates per 100.000 population. 1990 [demographic map]. Raleigh: North Carolina Dept. of Environment. Health. and Natural Resources. Div. of Epidemiology; 1991.
Example: The Quran. Othman Taha version.: Dar-al-Ghoran Publishing House: 1995. Maryam Surah. 1-18.
30. Dictionary and similar references
Example: Stedman's medical dictionary. 26th ed. Baltimore: Williams & Wilkins; 1995. Apraxia: p.119-20.
31. Classical match&
Example: The Winter's Tale: act 5. scene 1. lines 13-16. The complete works of William Shakespeare. London: Rex: 1973.
32. In press
Example: Leshner AI. Molecular mechanisms of cocaine addiction. N Engl J Med. In press 1996.
33. Journal article in electronic format
Example: Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5]; 1(1): [24 screens]. Available from: URL: http://www.cdc.gov/ ncidod/ EID/eid.htm
34. Monograph in electronic format
Example: CDI, clinical dermatology illustrated [monograph on CD-ROM]. Reeves JRT, Maibach H. CMEA Multimedia Group, producers. 2nd ed. Version 2.0. San Diego: CMEA; 1995.
35. Computer file
Example: Hemodynamics III: the ups and downs of hemodynamics [computer program]. Version 2.2. Orlando (FL): Computerized Educational Systems; 1993.
36. Web site / homepage
Elements of a citation: Author/Editor/Organization’s name. Title of the page [homepage on the Internet]. Place of publication: Publisher’s name; [updated yr month day; cited yr month day]. Available from: (URL)
Example: HeartCentreOnline [homepage on the Internet]. Boca Raton, FL: HeartCentreOnline, Inc.; c2000-2004 [updated 2004 May 23; cited 2004 Oct 15]. Available from: http://www.heartcenteronline.com/
37. Web Site/part of a Homepage:
Example: American Medical Association [homepage on the Internet]. Chicago: The American Medical Association; c1995-2002 [cited 2005 Apr 20]. Group and Faculty Practice Physicians; [about 2 screens]. Available from: http://www.ama-assn.org/ama/pub/category/1736.html
2.12. Units of Measurement
Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be given in Celsius. Blood pressures should be given in millimeters of mercury.
All clinical measurements should be reported in the metric system in terms of the International System of Units (SI).
2.13. Tables and Illustrations (Figures)
Type, insert or print out each Table with double spacing on appropriate place in the article. Do not submit tables as photographs. Number tables consecutively in the order of their first citation in the text and supply a brief caption for each. Give each column a short or abbreviated heading. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all nonstandard abbreviations that are used in each table. Captions or table legends should appear at the top of the tables.
Identify statistical measures of variations, such as standard deviation and standard error of the mean.
Be sure that each Table is cited in the text.
If you use data from another published or unpublished source, obtain permission and acknowledge them fully.
The use of too many tables in relation to the length of the text may produce difficulties in the layout of pages. You could include up to 10 illustrations (including images, graphs, charts, diagrams, and tables) with your submitted article considering the form at requirements.
Submit the required number of complete sets of figures. Figures should be professionally drawn and photographed; freehand or typewritten lettering is unacceptable. Instead of original drawings, x-ray films, and other material, insert sharp, glossy, black-and-white photographic prints, usually 127 x 173 mm (5 x 7 inches) but no larger than 203 x 254 mm (8 x 10 inches). Letters, numbers, and symbols should be clear and even throughout and of sufficient size that when reduced for publication each item will still be legible.
Each Figure should have a label pasted on its bottom indicating the number of the figure and author's name.
Photographs should have internal scale markers. Symbols, arrows, or letters used in photographs should contrast with the background.
Figures should be numbered consecutively according to the order in which they have been first cited in the text. If a figure has been published previously, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. Permission is required irrespective of authorship or publisher except for documents in the public domain.
Legends for Illustrations
Type or insert legends for illustrations using double spacing specifying each with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend. Explain the internal scale and identify the method of staining in photographs.
2.14. Abbreviations and Symbols
Use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
3. Sending the manuscript to the journal
Authors are encouraged to submit their manuscript electronically to the Journal Website (http:// JRSR.sums.ac.ir), and send a full copy of their manuscript with required formats (described in previous sections) to JRSR email.
3.2. Cover letter
Manuscripts must be accompanied by a covering letter signed by all coauthors. This must include 1) information on prior or duplicate publication or submission elsewhere of any part of the work as defined earlier in this document; 2) a statement of financial or other relationships that might lead to a conflict of interest 3) a statement that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met, and that each author believes that the manuscript represents honest work; and 4) the name, address, and telephone number of author(s), and specifying an author as corresponding person for communicating with the other authors about revisions and final approval of the proofs.
3.3. Copyrighted and Reprint Materials
The manuscript must be accompanied by copies of any permission to reproduce published material, to use illustrations or report information about identifiable people, or to name people for their contributions.
3.4. Statement of Sole Submission
The author(s) must guarantee that once their material has been accepted for publication by the JRSR, they will not make submission of the same material or portions thereof to another journal before publication in JRSR.
The editors also require that the author(s) be responsible for the linguistic and grammatical editing of their manuscript before submission to the Journal. Regretfully, sending such papers to peer reviewers will be delayed until the grammatical or linguistic errors are corrected by the author(s).
4. Quality Control and peer-Reviewing Process
Each submission to JRSR passes through a rigorous quality control and peer-review evaluation process before receiving a decision.Through a anonymize review, the articles will be reviewed by at least two external (peer) reviewers. Initially, articles which meet the minimum requirements for submission (such as including relevant title, abstract, the necessary descriptions of funding, privacy, ethics, statements of original work, having JRSR Record Form completed and signed by author(s), and so on,) are looked over by the executive manager. Once passed quality control, articles with good possibilities will be sent out for peer-review.
The peer-review process is designed to maintain scientifically credible information and research standards.It should be noted that articles submitted by the staff and editors of the JRSR will also be subjected to peer review and the editor plays no role in the review or decision.
Reviewers therefore should keep manuscripts and the information they contain strictly confidential. Reviewers must not publicly discuss authors' work and must not appropriate authors' ideas before the manuscript is published. Reviewers must not retain the manuscript for their personal use and should destroy copies of manuscripts after submitting their reviews.
Reviewers who seek assistance from a trainee or colleague in the performance of a review should acknowledge these individuals' contributions in the written comments submitted to the editor. Reviewers must maintain the confidentiality of the manuscript as outlined above, which may prohibit the uploading of the manuscript to software or other AI technologies where confidentiality cannot be assured. Reviewers should disclose to journals if and how AI technology is being used to facilitate their review. Reviewers should be aware that AI can generate authoritative-sounding output that can be incorrect, incomplete, or biased.
For a most targeted peer-reviewing process, authors are encouraged to enclose in their Cover Letter at least three in-field researchers/physicians, but the JRSR is not obliged to use that suggestions. Papers are critiqued and approved by at least two experts prior to being accepted for publication. If these reviews are positive, the article may be accepted immediately by the editorial board, or may be referred back to the authors to address any comments by the reviewers. If one review is positive and one is negative, a third peer review is scheduled and the editor decision is based upon the third reviewer's comment. However, if the two conducted reviews are negative, a rejection notification will be sent to the corresponding author. This notification means that the submitted work has not minimum requirement for possible publication in the JRSR. Nonetheless, other submissions by the same authors to the JRSR are welcomed.
5. Randomized controlled trials
All randomized controlled trials submitted for publication in JRSR should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart. Please refer to the CONSORT statement website at http://www.consort-statement.org for more information. The Journal has adopted the proposal from the International Committee of Medical Journal Editors (ICMJE) which require, as a condition of consideration for publication of clinical trials, registration in a public trials registry and CTIS (Clinical Trials Information System). Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article(https://www.who.int/clinical-trials-registry-platform/network/who-data-set)
. For this purpose, a clinical trial is defined as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g. phase I trials) would be exempt. Further information can be found at www.icmje.org.
JRSR Article Record For
JRSR recommends that you keep a copy of this completed form for reference purposes. Please ensure that this document is completed as fully and accurately as possible and has been signed by all coauthors. JRSR is unable to publish your work until a completed and signed Journal Article Record Form has been received. All coauthors are required to separately fill out and sign the form.
Article/ Case Report Title:
Please confirm the name of the corresponding author and their e-mail address:
Name and surname Signature
Note: For additional authors, please make another copy of this page and fill it out.
Each author(s) will receive 2 copies of the Journal upon publication involving their paper.
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
- The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
- Where available, URLs for the references have been provided.
- The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
- If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Double Blind Reviewhave been followed.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.